Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Fatty acid composition|
|Abstract:||Fatty acid composition comprising at least 80% by weight of omega-3-fatty acids, salts or derivatives thereof, wherein (all-Z)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z)-4,7,10,13,16,19-docosahexaenoic acid comprises at least 75% by weight of the total fatty acids. The compositions can be used for the treatment or prophylaxis of multiple risk factors for cardiovascular diseases.|
|Inventor(s):||Breivik; Harald (Skjelsvik, NO), Borretzen; Bernt (Porsgrunn, NO), Dahl; Knut H. (Ulefoss, NO), Krokan; Hans E. (Sjetnemarka, NO), Bonaa; Kaare H. (Tromso, NO)|
|Assignee:||Norsk Hydro A.S. (Oslo, NO)|
Patent Claim Types:|
see list of patent claims
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||8819110||Aug 11, 1988|
|Country||Document Number||Publication Date|
|Austria||A191889||Jun 15, 1994|
|Austria||398779||Jan 25, 1995|
|Australia||616784||Nov 07, 1991|
|Australia||3896789||Feb 15, 1990|
|Belgium||1002547||Mar 19, 1991|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.